The human orthologs of the ESCC miRNAs are also highly expressed in ESCs, are downregulated upon differentiation and regulate the cell cycle 2,9-12 . These miRNAs include members of the human miR-302 cluster (hsa-miR-302a-d), orthologous to the mouse miR-302s, and hsa-miR-372 and 373, orthologous to the mouse miR-291, miR-294 and miR-295 miRNAs. To determine whether these miRNAs play an analogous role in human somatic cell reprogramming, we introduced synthesized mimics of mature hsa-miR-302b and/or 372 into human foreskin (BJ) and lung fibroblasts (MRC-5) on days 3 and 10 after infection with combinations of retroviruses expressing OCT4, SOX2, KLF4, cMYC and Venus (4Y = OCT4, SOX2, KLF4, cMYC and Venus, whereas 3Y = OCT4, Sox2, KLF4 and Venus). An increase in number of colonies with human ESC-like morphology was observed in all wells transfected with mimics (Fig. 1a) . Most of the colonies showed retroviral silencing (as indicated by silencing of Venus expression), a strong indicator of full reprogramming to iPSCs 13 .
The embryonic stem cell-specific cell cycle-regulating (ESCC) family of microRNAs (miRNAs) enhances reprogramming of mouse embryonic fibroblasts to induced pluripotent stem cells 1 . Here we show that the human ESCC miRNA orthologs hsa-miR-302b and hsa-miR-372 promote human somatic cell reprogramming. Furthermore, these miRNAs repress multiple target genes, with downregulation of individual targets only partially recapitulating the total miRNA effects. These targets regulate various cellular processes, including cell cycle, epithelial-mesenchymal transition (EMT), epigenetic regulation and vesicular transport. ESCC miRNAs have a known role in regulating the unique embryonic stem cell cycle 2, 3 . We show that they also increase the kinetics of mesenchymal-epithelial transition during reprogramming and block TGFβ-induced EMT of human epithelial cells. These results demonstrate that the ESCC miRNAs promote dedifferentiation by acting on multiple downstream pathways. We propose that individual miRNAs generally act through numerous pathways that synergize to regulate and enforce cell fate decisions.
Dedifferentiation of a somatic cell to an induced pluripotent stem cell (iPSC) requires global epigenetic reprogramming and a shift in the expression of thousands of genes 4 . A number of small molecules and genes have been identified that increase the efficiency of reprogramming, but whether and how they converge into a common set of pathways is poorly understood 5, 6 . MiRNAs function by suppressing many mRNA targets simultaneously 7 . A large family of miRNAs highly expressed in mouse embryonic stem cells (ESCs) targets multiple inhibitors of the CyclinE-Cdk2 pathway, thereby promoting the unique cell cycle program of these cells 3 . This family, termed ESCC miRNAs, greatly enhances the reprogramming efficiency of mouse embryonic fibroblasts into iPSCs, as does the closely related miR-106 family 1, 8 . Together, these data suggest a pathway for downregulation of cell cycle inhibitors by the ESCC miRNAs during reprogramming, resulting in increased efficiency of dedifferentiation. However, as miRNAs target hundreds of mRNAs, it is likely that cell cycle regulation is only part of the mechanism. l e t t e R s have been shown to enhance reprogramming to mouse and human iPSCs [20] [21] [22] . Consistent with these reports, we observed an increase in reprogramming efficiency with both 4Y and 3Y upon addition of RepSox, a TβRI inhibitor (Fig. 2b,c) . Furthermore, expression of the type II TGF-β receptor cDNA (TβRII) without its 3′ UTR or addition of TGF-β ligand abolished iPSC generation (Supplementary Fig. 3 ), overriding the positive effects of miR-302b and miR-372. For the remaining 11 significantly downregulated target genes, siRNA pools against each target were transfected together with transduction of 4Y or 3Y. All siRNA pools robustly suppressed their target gene ( Supplementary  Fig. 4) . Five of the 11 knockdowns significantly increased the number of iPSC colony numbers in combination with 4Y, and four did so with 3Y, totaling six independent gene knockdowns enhancing reprogramming (Fig. 2b,c) . However, the increases were modest, with few reaching levels seen with miR-372. As downregulation of RHOC expression significantly enhanced the reprogramming efficiencies of both 4Y and 3Y, we tested an alternative means of repressing RHO functions. Y-27632 (ROCKi) is a small-molecule inhibitor of the RHO-dependent protein kinase ROCK, which acts immediately downstream of RHO 23 . ROCKi enhances survival of dissociated hESCs 24-26 but has not been previously shown to enhance reprogramming. We found that the combination of ROCKi together with 4Y or 3Y indeed increased colony number (Fig. 2b,c) .
As inhibition of RHOC and TβRI signaling enhanced reprogramming, we explored whether these two pathways synergized to regulate this process by conducting 3Y and 4Y reprogramming in the presence of ROCKi, RepSox or both molecules. Indeed, various combinations of ROCKi, RepSox and miR-372 also resulted in a significant increase in colony number compared to mock-transfected cells (Fig. 2b,c) . The increase in efficiency observed upon using combinations of inhibitors in 3Y-infected cells was significantly higher than when a single inhibitor was used and reached levels seen with miR-372 (Fig. 2c) . Together, these results are consistent with the ESCC miRNAs acting through multiple targets and/or pathways to enhance reprogramming. essential role of seed sequence-based targeting in the enhancement of reprogramming.
We sought to identify the genes and mechanisms by which miR-302b and miR-372 enhance human iPSC production. Previous mRNA profiling after introduction of the miRNAs into miRNA-deficient mouse ESCs, together with bioinformatic analysis for seed matches in the mRNAs, had identified a set of putative miR-294 target genes 16 . As miR-302b and 372 share the same seed sequence as miR-294, this compilation likely represents a set of putative targets for the entire ESCC miRNA family. From this list, we chose a subset of target genes for further testing to determine whether they were targeted during the reprogramming process (Supplementary Table 1 ). Transcript levels of 34 putative targets were quantified by RT-qPCR on day 7 of 4Y-or 3Y-mediated reprogramming in the presence or absence of the miRNAs ( Fig. 2a and Supplementary Fig. 2 ). Among these, 12 transcripts (labeled in red) showed statistically significant decreases in levels after transfection of the miRNA in cells that had been infected with either 4Y or 3Y (P < 0.05). An additional 15 transcripts were downregulated at levels that did not reach our significance cut-off but are still probably meaningful as cells undergoing reprogramming are heterogeneous and miRNA effects on mRNA stability are typically slight. Notably, after miRNA transfection into uninfected BJ fibroblasts only a few of the putative targets were downregulated, suggesting context-dependent effects. The 12 target genes that were significantly downregulated during reprogramming were further characterized. The mRNAs fell into several functional modules: (i) cell cycle regulation (CDKN1A, RBL2, CDC2L6); (ii) epigenetic regulation (MECP2, MBD2, SMARCC2); (iii) vesicular transport (RAB5C, RAB11FIP5); (iv) cell signaling (AKT1, ARHGAP26); and (v) epithelial-mesenchymal transition (RHOC, TGFBR2). Of these, CDKN1A, RBL2 and MECP2 have been previously described as targets of miR-302b/372 (refs. 2,3,17-19) .
Next, we evaluated the potential contribution to reprogramming of the individual target genes that are significantly downregulated by the miRNAs. Inhibitors to the type I TGF-β receptor (TβRI) kinase 
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the miRNAs only in the context of reprogramming and SLUG showed a decrease with miR-372 during reprogramming. The transcription factors ZEB1, ZEB2 and SLUG are not only markers of the mesenchymal fate but also directly inhibit the epithelial fate in part by inhibiting the expression of E-cadherin 31 . Indeed, E-cadherin (CDH1) expression and, to a lesser extent, the expression of the epithelial markers, occludin (OCLN) and EP-CAM, were upregulated at day 7 of reprogramming with the addition of miRNAs ( Fig. 3c and Supplementary Fig. 6 ). In contrast, the introduction of miRNAs alone into uninfected fibroblasts was unable to induce expression of the epithelial markers ( Fig. 3c and Supplementary Fig. 6 ).
To more closely follow the kinetics of MET with and without the introduction of the miRNAs, we examined the appearance of epithelial markers by immunoblotting and immunocytochemistry at different To verify that the ESCC miRNAs enhance reprogramming through multiple transcripts, we evaluated the two novel targets, RHOC and TGFBR2. Consistent with the RT-qPCR data, western blots showed that the level of TβRII protein was suppressed by miR-302b and miR-372 during reprogramming (Fig. 3a) . TGFBR2 mRNA has three 7-mer seed matches and three 6-mer seed matches in its 3′UTR (Fig. 3b, schematic) . The 3′UTR was fused to a luciferase reporter and introduced into miRNA-deficient mouse ESCs in the presence and absence of the miRNA mimics. Luciferase activity was significantly reduced in the presence of the ESCC miRNAs (Fig. 3b, top panel) but not when mutations were introduced into the seed sequence of the mimics (Fig. 3b,  middle panel) . Furthermore, mutation of the 7-mer seed matches in the TGFBR2 mRNA 3′UTR resulted in a significant recovery of luciferase activity (Fig. 3b, top panel, and Supplementary Fig. 5 ). Incomplete recovery is likely due to the existence of additional target sites in the TGFBR2 3′UTR (Fig. 3b) . In contrast to the TGFBR2 mRNA, RHOC mRNA has only one 7-mer seed match in its 3′UTR (Fig. 3b, schematic) . The 3′UTR still suppressed luciferase activity, albeit to a lesser degree, and was fully reversed by inserting mutations into the predicted site (Fig. 3b,  bottom panel) . Together, these data illustrate that the genes encoding RHOC and TGFBR2 are direct targets of the ESCC miRNAs. miR-302 was previously shown to enhance Nodal signaling, another member of the TGF-β family, by targeting Lefty1 and Lefty2 transcripts during early hESC differentiation, promoting mesoendodermal cell fates 27 . However, the genes encoding Lefty1 and Lefty2 were expressed at low levels during reprogramming to iPSCs and were not downregulated by the ESCC miRNAs (data not shown), suggesting cell context-specific effects.
The finding that miR-302b and miR-372 inhibited TGFBR2 and RHOC expression, and to a lesser extent, the expression of SMAD2, INHBB, GAPs and GEFs (Fig. 2a) is intriguing as these signaling mediators regulate the choice between epithelial and mesenchymal cell fates 28 . Recent work has shown that mouse fibroblasts undergo a mesenchymalepithelial transition (MET) early in the process of reprogramming 29, 30 . Therefore, we hypothesized that miR-302b and miR-372 may increase reprogramming efficiency by accelerating MET. To test this hypothesis, we followed marker expression during reprogramming with or without the addition of miR-302b and miR-372. RT-qPCR was performed on RNA isolated 7 d after transduction (4 d after transfection of miRNAs) of human fibroblasts. The addition of miR-302b and/ or miR-372 decreased the levels of the mesenchymal markers ZEB1 and FN1, independent of the introduction of reprogramming factors, and consistent with the presence of seed matches in their ORF or 3′UTR (Fig. 3c,  Supplementary Fig. 6 
miR-372, relative to 4Y alone, and could be seen in 3Y cells only in the presence of miR-372. Similar enhancement in E-cadherin levels was also observed upon treatment of cells with either ROCKi (Supplementary  Fig. 7b ) or RepSox (Supplementary Fig. 7c) . Immunocytochemistry was performed to detect the expression of the epithelial markers JAM-1 and E-cadherin (Fig. 3d) , and the organization of F-actin, whose distribution changes dramatically during MET ( Supplementary  Fig. 8 ). Cells transduced with 4Y alone began expressing JAM-1 at day 8 and E-cadherin at day 15 after infection. When supplemented with miR-372, the expression of JAM-1 and E-cadherin was accelerated to days 5 and 8, respectively. Similar to 4Y infection of cells, miR-372 accelerated the initiation of JAM-1 expression from day 15 to day 10 in 3Y-infected cells. E-cadherin expression was not detected in this time course with 3Y-infected cells but was robust at day 18 with the addition of miR-372 (Fig. 3d) . These changes coincided with the relocalization of F-actin in the cells. That is, the actin filaments acquired a cortical organization during dedifferentiation, which occurred earlier in 3Y with addition of the miRNAs (Supplementary Fig. 8) . Importantly, the appearance of E-cadherin expression coincided with the emergence of completely reprogrammed colonies in the presence of the miRNAs ( Supplementary  Fig. 9 ). Together, these results support a role for the occurrence of MET during the course of reprogramming of human cells, similar to what was described for mouse cells 29, 30 , and illustrate that the ESCC miRNAs increase the efficiency of reprogramming in part by inducing more efficient MET. We next investigated whether these miRNAs are general stabilizers of the epithelial cell fate. TGF-β can induce an EMT in epithelial cells 28 . We therefore asked whether miR-302b and miR-372 could inhibit TGF-β-induced EMT in human keratinocyte HaCaT cells. HaCaT cells were treated with TGF-β 2 d after transfection with miRNA mimics. miR-302b/372 decreased TβRII levels without affecting TβRI levels in HaCaT cells (Fig. 4a) . Moreover, the ESCC miRNAs inhibited TGF-β-induced SMAD2 and SMAD3 phosphorylation in response to TGF-β, compared to control untreated cells (Fig. 4a) . Without TGF-β treatment, the expression of miR-302b/372 did not affect the epithelial morphology of HaCaT cells, as observed by phase contrast microscopy (Fig. 4b) , cortical actin organization and the presence of E-cadherin and ZO-1 at cellcell junctions (Fig. 4c) . After 72 h of TGF-β treatment, HaCaT cells underwent EMT with dramatic morphological changes accompanied by cell individualization (Fig. 4b) , actin reorganization into stress fibers, and loss of E-cadherin and ZO-1 expression (Fig. 4c) . In time points during reprogramming. Immunoblotting clearly showed earlier and stronger expression of E-cadherin in the presence of miR-372 (Supplementary Fig. 7a ). At day 10, E-cadherin was robustly expressed in 4Y-infected cells plus miR-372 but barely visible in 4Y alone or 3Y plus miR-372. At day 18, E-cadherin expression was higher in 4Y cells plus 
of mouse ESCs by targeting inhibitors of the G1/S transition, including p21 (CdkN1A), Lats2 and Rbl2 (ref. 3) , and have analogous effects on the human ESC cell cycle 2 . Accordingly, these miRNAs are expected to enhance reprogramming through their effects on the cell cycle. Indeed, knockdown of p21 during reprogramming has been shown to enhance induced pluripotency [33] [34] [35] [36] . Here we show that RBL2 knockdown also enhances reprogramming. However, because the ESCC miRNAs have hundreds of target genes 16 , we tested a larger subset of these targets in reprogramming. We show that, in addition to their effects on cell cycle regulators, these miRNAs also target genes involved in epigenetic regulation, vesicular transport and MET during reprogramming, and that downregulation of many of these target genes increases the number of iPSC colonies produced. Follow-up experiments confirmed that the ESCC miRNAs function in part through MET by targeting at least TGFBR2 and RHOC, but also likely SMAD2, ZEB1 and FN1 to enhance reprogramming. Future experiments are likely to confirm the role of additional pathways downstream of these miRNAs. Indeed, our contrast, expression of miR-302b and miR-372 substantially inhibited TGF-β-induced EMT in HaCaT cells. The cells failed to spread and maintained their cell-cell contacts resembling an epithelial phenotype (Fig. 4b) . In addition, E-cadherin and ZO-1 remained localized at the cell-cell junctions, as revealed by immunofluorescence (Fig. 4c) . Confirming these observations, E-cadherin expression was higher in miR-302b/372-transfected cells compared to control cells after 48 h of TGF-β treatment (Fig. 4d) . The expression of the transcriptional repressor SLUG is normally upregulated in TGF-β-induced EMT, repressing CDH1 transcription 28 . Its expression was reduced in HaCaT cells transfected with miR302b/372, compared to control cells after 24 h of TGF-β treatment (Fig. 4e) . Notably, each of these effects on EMT was completely abrogated when the seed sequence was mutated in the mimics ( Supplementary  Fig. 10 ). These results demonstrate that miR-302b and miR-372 are potent inhibitors of TGF-β-induced EMT as well as promoters of MET during reprogramming.
To determine whether these effects were conserved among the ESCC miRNAs, we included the mimic for the mouse ESCC homolog mmumiR-294, which contains the same seed sequence as hsa-miR-302b/372 (Fig. 4a) . The mmu-miR-294 mimic yielded similar results to those of the human ESCC miRNAs, and these effects were abrogated by disrupting the seed sequence, indicating a highly conserved and seeddependent role of ESCC miRNAs in regulating EMT.
Taken together, our findings show that the ESCC miRNAs enhance the efficiency of reprogramming to induced pluripotency by targeting multiple mRNAs enriched in various important cellular processes. Others have suggested that miR-302a-d alone can promote dedifferentiation of cancer cells and human hair follicle cells to an iPSC-like state 18, 32 . The ESCC miRNAs regulate the unique cell cycle program 
results would argue that miRNAs could be used as a powerful means to uncover many if not all the pathways important for the induction of pluripotency or any cell fate transition of interest.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nbt/index.html.
